Craig Johnson

(Mr. Craig Johnson CPA)

Currently holds positions in Novadel Pharma Inc, Mirati Therapeutics Inc, La Jolla Pharmaceutical Co, Heron Therapeutics Inc and Odonate Therapeutics Inc

Positions

Position Company Period
Chief Financial Officer, Senior Vice President, Secretary Novadel Pharma Inc June 16, 2010 -
Independent Director Mirati Therapeutics Inc Aug. 30, 2013 -
Independent Director La Jolla Pharmaceutical Co Oct. 14, 2013 -
Independent Director Heron Therapeutics Inc Jan. 10, 2014 -
Independent Director Odonate Therapeutics Inc July 1, 2017 -
Independent Director Adamis Pharmaceuticals Corp Feb. 10, 2011 - Aug. 25, 2014
Independent Director Ardea Biosciences Inc July 1, 2008 - June 19, 2012
Chief Financial Officer PURE Biosciences Inc Aug. 1, 2011 - May 4, 2012
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2021-12-23 2021-12-21 PS Planned sale
250 -8.1%
9.73
USD 2,432
250 -8.1% 9.73 USD 2,432
2021-06-22 2021-06-21 PS Planned sale
250 -7.0%
15.20
USD 3,801
250 -7.0% 15.20 USD 3,801
2021-04-07 2021-04-06 PS Planned sale
250 -6.5%
17.22
USD 4,305
250 -6.5% 17.22 USD 4,305
2021-01-25 2021-01-21 PS Planned sale
334 -8.8%
214.75
USD 71,728
334 -8.8% 214.75 USD 71,728
2021-01-25 2021-01-21 PS Planned sale
44 -1.1%
213.62
USD 9,399
44 -1.1% 213.62 USD 9,399
2021-01-25 2021-01-21 PS Planned sale
3,372 -46.7%
212.97
USD 718,151
3,372 -46.7% 212.97 USD 718,151
2021-01-25 2021-01-21 PS Planned sale
4,562 -38.7%
211.94
USD 966,852
4,562 -38.7% 211.94 USD 966,852
2021-01-25 2021-01-21 PS Planned sale
3,183 -21.3%
210.81
USD 671,004
3,183 -21.3% 210.81 USD 671,004
2021-01-25 2021-01-21 PS Planned sale
3,505 -19.0%
210.01
USD 736,070
3,505 -19.0% 210.01 USD 736,070
2020-04-21 2020-04-20 PS Planned sale
15,000 -88.2%
93.00
USD 1,395,000
15,000 -88.2% 93.00 USD 1,395,000
2019-01-31 2019-01-29 PS Planned sale
8,525 -100.0%
61.80
USD 526,831
8,525 -100.0% 61.80 USD 526,831
2019-01-31 2019-01-29 PS Planned sale
8,475 -49.9%
61.11
USD 517,941
8,475 -49.9% 61.11 USD 517,941
// ... existing code ... // ... rest of the file ...